Hanmi, “Clinical trials of new drug transferred to Janssen has never been suspended”
When it comes to the online article from an economic newspaper on the 7th, ‘Hanmi Pharm suspends clinical trial of the drug candidate transferred to Janssen,’ Hanmi Pharm announced that the clinical trial of the new drug whose technology was transferred to Janssen has never been suspended on the ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
